 Jitao Guo
Concepts (44)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| T-Lymphocytes, Regulatory | 2 | 2015 | 373 | 0.750 |
Why?
| | Cell Engineering | 1 | 2021 | 9 | 0.740 |
Why?
| | Cancer Vaccines | 1 | 2019 | 164 | 0.570 |
Why?
| | Neoplasms | 3 | 2021 | 2455 | 0.540 |
Why?
| | Dendritic Cells | 1 | 2019 | 481 | 0.500 |
Why?
| | Lymphocyte Activation | 2 | 2019 | 1109 | 0.460 |
Why?
| | Health | 1 | 2015 | 75 | 0.460 |
Why?
| | MAP Kinase Kinase 1 | 1 | 2014 | 75 | 0.450 |
Why?
| | Protein Kinase Inhibitors | 1 | 2019 | 887 | 0.420 |
Why?
| | MAP Kinase Signaling System | 1 | 2014 | 313 | 0.390 |
Why?
| | Autoimmune Diseases | 1 | 2015 | 427 | 0.360 |
Why?
| | Yersinia pestis | 1 | 2011 | 44 | 0.350 |
Why?
| | Antimicrobial Cationic Peptides | 1 | 2011 | 77 | 0.350 |
Why?
| | Drug Resistance, Bacterial | 1 | 2011 | 175 | 0.330 |
Why?
| | Anti-Infective Agents | 1 | 2011 | 247 | 0.300 |
Why?
| | Chromones | 1 | 2019 | 45 | 0.160 |
Why?
| | Heterocyclic Compounds, 3-Ring | 1 | 2019 | 31 | 0.160 |
Why?
| | Morpholines | 1 | 2019 | 122 | 0.150 |
Why?
| | Cell Communication | 1 | 2019 | 301 | 0.140 |
Why?
| | T-Lymphocyte Subsets | 1 | 2019 | 412 | 0.130 |
Why?
| | Models, Immunological | 1 | 2015 | 95 | 0.120 |
Why?
| | Luciferases | 1 | 2014 | 147 | 0.110 |
Why?
| | MAP Kinase Kinase Kinases | 1 | 2014 | 70 | 0.110 |
Why?
| | Immunity | 1 | 2015 | 138 | 0.110 |
Why?
| | Encephalomyelitis, Autoimmune, Experimental | 1 | 2014 | 61 | 0.110 |
Why?
| | Forkhead Transcription Factors | 1 | 2014 | 183 | 0.110 |
Why?
| | Mice, Inbred NOD | 1 | 2014 | 587 | 0.100 |
Why?
| | RNA Interference | 1 | 2014 | 450 | 0.100 |
Why?
| | Enzyme Activation | 1 | 2014 | 813 | 0.100 |
Why?
| | HEK293 Cells | 1 | 2014 | 698 | 0.100 |
Why?
| | Blotting, Western | 1 | 2014 | 1206 | 0.090 |
Why?
| | Protamines | 1 | 2011 | 7 | 0.090 |
Why?
| | Polymyxin B | 1 | 2011 | 20 | 0.090 |
Why?
| | Mutagenesis, Insertional | 1 | 2011 | 65 | 0.090 |
Why?
| | Proto-Oncogene Proteins | 1 | 2014 | 636 | 0.090 |
Why?
| | Antineoplastic Combined Chemotherapy Protocols | 1 | 2019 | 1560 | 0.090 |
Why?
| | DNA Transposable Elements | 1 | 2011 | 119 | 0.080 |
Why?
| | Mice, Transgenic | 1 | 2014 | 2128 | 0.080 |
Why?
| | Humans | 4 | 2021 | 129627 | 0.060 |
Why?
| | Animals | 2 | 2019 | 35391 | 0.060 |
Why?
| | Mice, Inbred C57BL | 1 | 2014 | 5455 | 0.050 |
Why?
| | Mice | 1 | 2019 | 16961 | 0.050 |
Why?
| | Male | 2 | 2019 | 63671 | 0.040 |
Why?
| | Female | 1 | 2014 | 68735 | 0.020 |
Why?
|
|
Guo's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|